| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $23,994,552 ) (Continued on the next page) |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01CA279546 | Causes and Consequences of Whole Genome Duplication in Cancer Progression and Acquired Drug Resistance | 000 | 2 | NIH | 11/26/2024 | $416,314 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069518 | The Johns Hopkins University-Blantyre Clinical Trials Unit | 001 | 19 | NIH | 11/6/2024 | $35,537 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069518 | The Johns Hopkins University-Blantyre Clinical Trials Unit | 001 | 19 | NIH | 11/6/2024 | $722,539 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R21AI173475 | Identifying Optimal Antibiotic Treatment for Non-CTX-M-Producing ESBL Bloodstream Infections | 000 | 2 | NIH | 10/24/2024 | $204,688 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R03AI180804 | Image-based quantification of Plasmodium sporozoites in a single oocyst using deep learning-based segmentation and 3D reconstruction | 000 | 2 | NIH | 10/24/2024 | $79,419 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01AG085688 | MIF Nuclease actions in Synuclein Dementias | 000 | 2 | NIH | 11/22/2024 | $736,580 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | P30HS029772 | Promoting Embedded Research in a Learning Health System | 000 | 2 | AHRQ | 11/27/2024 | $999,999 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01AI148332 | A Ring Water, Sanitation, and Hygiene Intervention to Reduce Cholera in Hotspots in Bangladesh | 000 | 5 | NIH | 11/7/2024 | $829,453 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R13DC018475 | CogHear: Cognitive Hearing workshop series | 000 | 4 | NIH | 11/4/2024 | $40,000 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F32HD117584 | Microbiome-induced changes following influenza infection during pregnancy | 000 | 1 | NIH | 11/7/2024 | $74,764 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01MD017048 | Hidden in Plain Sight: Stigmatizing Language in Patient Medical Records | 001 | 4 | NIH | 11/28/2024 | $613,758 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01NS110098 | Investigating Dysregulation of Stress-related Ribonucleoprotein Granules and Functions of Associated RNA-binding Proteins in ALS/FTD | 002 | 7 | NIH | 11/25/2024 | $564,290 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F31MH135787 | Extending the Prevention Toolbox: Exploring the Acceptability and Impact of Long-acting Injectable PrEP among MSM in Baltimore: A Pilot Study | 000 | 2 | NIH | 11/4/2024 | $48,974 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01ES033739 | Statistical methods for air-pollution studies using low-cost monitors | 000 | 4 | NIH | 11/15/2024 | $221,063 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01DK128933 | Regulators of adipocyte oxidative metabolism | 000 | 4 | NIH | 11/15/2024 | $398,189 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F31EY037171 | Evaluation of Human Retinal Ganglion Cell Regenerative Potential | 001 | 1 | NIH | 11/15/2024 | $0 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F31EY037171 | Evaluation of Human Retinal Ganglion Cell Regenerative Potential | 000 | 1 | NIH | 11/15/2024 | $48,974 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01AG082315 | Impact of APOE deficiency on HPA axis function and cognition | 000 | 2 | NIH | 11/15/2024 | $643,845 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | K23AI159145 | Optimizing Anti-mycobacterial Therapy Using A Pharmacology-based Approach | 000 | 4 | NIH | 11/14/2024 | $198,720 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069465 | Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU) | 000 | 19 | NIH | 11/14/2024 | $361,116 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069465 | Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU) | 000 | 19 | NIH | 11/14/2024 | $860,245 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R21AI183368 | Mechanisms of Varicella Zoster Virus Latency in Human Sensory Neurons | 000 | 2 | NIH | 11/13/2024 | $198,547 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01DC019686 | K-HEARS: Hearing Health Equity through Accessible Research and Solutions for Korean Americans | 001 | 2 | NIH | 11/26/2024 | $617,257 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | K08AI174959 | Mechanisms of a therapeutic DNA vaccine targeting Mycobacterium tuberculosis persisters | 000 | 2 | NIH | 11/12/2024 | $200,880 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01AI182234 | Chemosensory Mechanisms Driving Malaria Transmission | 000 | 1 | NIH | 11/15/2024 | $707,696 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01EY035807 | Early development of higher visual motion area PSS mechanisms and consequences | 000 | 2 | NIH | 11/15/2024 | $426,801 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R21AI188223 | Targeting a reductive dehalogenase as a new strategy for controlling mosquito populations | 000 | 1 | NIH | 11/12/2024 | $211,038 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R00GM151485 | The functional and adaptive roles of RNA recoding | 000 | 3 | NIH | 11/26/2024 | $249,000 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 000 | 19 | NIH | 11/27/2024 | $4,403,301 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 000 | 19 | NIH | 11/27/2024 | $1,075,000 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 000 | 19 | NIH | 11/27/2024 | $375,000 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 000 | 19 | NIH | 11/27/2024 | $3,500,000 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01DK093770 | Novel Kidney Injury Tools in Deceased Organ Donation to Predict Graft Outcomes | 000 | 12 | NIH | 11/28/2024 | $613,979 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01AI165826 | Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75 | 000 | 4 | NIH | 11/25/2024 | $1,583,019 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 000 | 19 | NIH | 11/22/2024 | $258,476 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 000 | 19 | NIH | 11/22/2024 | $1,416,707 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 000 | 19 | NIH | 11/22/2024 | $657,416 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 000 | 19 | NIH | 11/22/2024 | $2,261,629 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F31NS135935 | Characterizing novel Mixed Etiology Dementia models compromised for TDP-43 function | 000 | 2 | NIH | 11/22/2024 | $42,574 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01HD108905 | Nanomedicine-based approach for characterizing the epigenome in prevention of inflammation-induced preterm birth. | 000 | 3 | NIH | 11/22/2024 | $547,632 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01DC019359 | The function of LIN28B and follistatin in supporting cell reprogramming and hair cell regeneration in the murine cochlea | 000 | 4 | NIH | 11/18/2024 | $436,300 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01CA051497 | Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis | 000 | 33 | NIH | 11/20/2024 | $298,434 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | K23HL161449 | Optimizing Respiratory Culture Practices for Mechanically Ventilated Children | 000 | 4 | NIH | 11/19/2024 | $198,720 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01AI172546 | The role of neutralizing antibodies in natural and treatment-induced control of hepatitis B with and without HIV-1 co-infection | 000 | 3 | NIH | 11/20/2024 | $368,297 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | K24AI141580 | Mentoring in prevention of healthcare-associated infections and antibiotic resistance | 000 | 7 | NIH | 11/21/2024 | $162,026 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01AI189309 | Impact of Gender Affirming Hormone Therapy on HIV Viral Dynamics and Immune Responses in Transgender Women | 000 | 1 | NIH | 11/18/2024 | $771,490 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F32HL172535 | The Association of Pneumonia-Related Financial Toxicity with Subsequent Outcomes | 000 | 2 | NIH | 11/20/2024 | $44,966 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | K23AI159143 | Patient-Centered Outcomes of the First Approved Peanut Allergy Treatment | 000 | 4 | NIH | 11/21/2024 | $198,720 |
| 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R37HD037047 | Regulation of Germ Cell Fate During Embryogenesis | 000 | 25 | NIH | 11/6/2024 | $361,069 |
|